Diana Wong’s Post

View profile for Diana Wong, graphic

Chief Operating Officer, Veramed

In a groundbreaking development, the AI breast screening tool, Mia, has helped detect 12% more breast cancers in the UK, marking a significant improvement in early detection. This AI solution, developed by Kheiron Medical Technologies in collaboration with NHS Grampian, the University of Aberdeen, and Microsoft, has the potential to transform breast cancer outcomes across the country. If implemented nationwide, this could lead to better outcomes for thousands of women and a potential 30% reduction in workload for radiologists. Notably, Mia’s ability to identify cancers, especially high-grade ones, at an earlier stage means earlier treatment and a higher chance of survival. As one of the first patients detected by Mia shared, “It’s a life saver, it’s a life changer.” The AI-driven solution not only boosts detection rates but also minimizes unnecessary recalls, reducing stress and anxiety for patients. This collaboration showcases the incredible potential of AI in healthcare, offering new hope in the fight against cancer. As AI continues to prove its value in healthcare, we're eager to see what other diagnostic applications it will tackle next! #AI #Healthcare #BreastCancer #Innovation https://okt.to/Vc5Efb

AI detects 12% more breast cancers in UK first - Microsoft UK Stories

AI detects 12% more breast cancers in UK first - Microsoft UK Stories

https://ukstories.microsoft.com

David Potter

Connecting leaders in Life Sciences | Biotech | Medtech

3mo

A fantastic application of the technology - I hope to see this, and others, rolled out as widely as possible.

To view or add a comment, sign in

Explore topics